CHRDL1
Basic information
Region (hg38): X:110673856-110795819
Previous symbols: [ "MGC1" ]
Links
Phenotypes
GenCC
Source:
- isolated congenital megalocornea (Strong), mode of inheritance: XL
- isolated congenital megalocornea (Supportive), mode of inheritance: XL
- isolated congenital megalocornea (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Megalocornea 1, X-linked | XL | Ophthalmologic | Individuals may be at risk for manifestations such as cataract development and glaucoma after lenticular dislocation or subluxation, and awareness may allow early management of sequelae | Ophthalmologic | 2571565; 22284829; 24073597; 25093588 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (34 variants)
- not_provided (25 variants)
- Megalocornea (16 variants)
- CHRDL1-related_disorder (5 variants)
- Isolated_congenital_megalocornea (4 variants)
- Corneal_disorder (1 variants)
- not_specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHRDL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001143981.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 41 | 50 | ||||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 17 | 4 | 41 | 8 | 6 |
Highest pathogenic variant AF is 0.00000199211
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHRDL1 | protein_coding | protein_coding | ENST00000372042 | 11 | 122203 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.216 | 0.783 | 125727 | 2 | 6 | 125735 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.450 | 161 | 178 | 0.905 | 0.0000135 | 3012 |
Missense in Polyphen | 71 | 74.837 | 0.94873 | 1222 | ||
Synonymous | -0.199 | 65 | 63.0 | 1.03 | 0.00000480 | 834 |
Loss of Function | 3.13 | 5 | 20.2 | 0.248 | 0.00000161 | 327 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000110 | 0.000110 |
Ashkenazi Jewish | 0.000274 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000625 | 0.0000462 |
European (Non-Finnish) | 0.0000250 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Antagonizes the function of BMP4 by binding to it and preventing its interaction with receptors. Alters the fate commitment of neural stem cells from gliogenesis to neurogenesis. Contributes to neuronal differentiation of neural stem cells in the brain by preventing the adoption of a glial fate. May play a crucial role in dorsoventral axis formation. May play a role in embryonic bone formation (By similarity). May also play an important role in regulating retinal angiogenesis through modulation of BMP4 actions in endothelial cells. Plays a role during anterior segment eye development. {ECO:0000250, ECO:0000269|PubMed:18587495, ECO:0000269|PubMed:22284829}.;
- Disease
- DISEASE: Megalocornea 1, X-linked (MGC1) [MIM:309300]: An eye disorder in which the corneal diameter is bilaterally enlarged (greater than 13 mm) without an increase in intraocular pressure. It may also be referred to as anterior megalophthalmos, since the entire anterior segment is larger than normal. Features of megalocornea in addition to a deep anterior chamber include astigmatic refractive errors, atrophy of the iris stroma, miosis secondary to decreased function of the dilator muscle, iridodonesis, and tremulousness, subluxation, or dislocation of the lens. Whereas most affected individuals exhibit normal ocular function, complications include cataract development and glaucoma following lenticular dislocation or subluxation. {ECO:0000269|PubMed:22284829}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signal Transduction;Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);BMP receptor signaling;BMP Signalling Pathway;Signaling by BMP;Signaling by TGF-beta family members
(Consensus)
Recessive Scores
- pRec
- 0.380
Intolerance Scores
- loftool
- 0.698
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- 0.407
- hipred
- Y
- hipred_score
- 0.528
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chrdl1
- Phenotype
Gene ontology
- Biological process
- ossification;eye development;nervous system development;cell differentiation;BMP signaling pathway;negative regulation of BMP signaling pathway;post-translational protein modification;cellular protein metabolic process;compound eye development
- Cellular component
- extracellular region;endoplasmic reticulum lumen
- Molecular function